Markus Krumbholz

11.1k total citations · 1 hit paper
69 papers, 6.3k citations indexed

About

Markus Krumbholz is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Markus Krumbholz has authored 69 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 25 papers in Neurology and 25 papers in Immunology. Recurrent topics in Markus Krumbholz's work include Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (15 papers) and Immunotherapy and Immune Responses (11 papers). Markus Krumbholz is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (15 papers) and Immunotherapy and Immune Responses (11 papers). Markus Krumbholz collaborates with scholars based in Germany, United States and Switzerland. Markus Krumbholz's co-authors include Edgar Meinl, Reinhard Hohlfeld, Tobias Derfuß, Dieter E. Jenne, Volker Brinkmann, Kai Kessenbrock, Zena Werb, Hermann-Josef Gröne, Wolfgang L. Gross and Walter Back and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Markus Krumbholz

66 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Netting neutrophils in autoimmune small-vessel vasculitis

2009 1.3k citations Markus Krumbholz et al. profile →

Peers

Countries citing papers authored by Markus Krumbholz

Since Specialization

Citations

This map shows the geographic impact of Markus Krumbholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Krumbholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Krumbholz more than expected).

Fields of papers citing papers by Markus Krumbholz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Krumbholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Krumbholz. The network helps show where Markus Krumbholz may publish in the future.

Co-authorship network of co-authors of Markus Krumbholz

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Krumbholz. A scholar is included among the top collaborators of Markus Krumbholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Krumbholz. Markus Krumbholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous temperature monitoring in patients with spontaneous intracerebral hemorrhage: insights into temperature patterns and variability 2025 ·Journal of Stroke and Cerebrovascular Diseases ·(unknown), Annerose Mengel, Maria‐Ioanna Stefanou, (unknown), (unknown), (unknown), Till‐Karsten Hauser, Ulf Ziemann, Markus Krumbholz, Katharina Feil	0
2	Continuous Blood Pressure Indices During the First 72 Hours and Functional Outcome in Patients with Spontaneous Intracerebral Hemorrhage 2024 ·Neurocritical Care ·Annerose Mengel, Vasileios Siokas, (unknown), (unknown), (unknown), (unknown), Efthimios Dardiotis, (unknown), (unknown), Till‐Karsten Hauser, Markus Krumbholz, Ulf Ziemann, Katharina Feil	3
3	Continuous arterial blood pressure indices and early hematoma expansion in patients with spontaneous intracerebral hemorrhage 2024 ·SHILAP Revista de lepidopterología ·Annerose Mengel, Vasileios Siokas, (unknown), (unknown), (unknown), (unknown), Efthimios Dardiotis, (unknown), (unknown), (unknown), Antje Giede-Jeppe, Till‐Karsten Hauser, Sven Poli, Markus Krumbholz, Ulf Ziemann, Katharina Feil	5
4	Heart Rate Variability and Functional Outcomes of Patients with Spontaneous Intracerebral Hemorrhage 2024 ·Biomedicines ·(unknown), Annerose Mengel, (unknown), (unknown), Maria‐Ioanna Stefanou, (unknown), Till‐Karsten Hauser, Markus Krumbholz, Ulf Ziemann, Katharina Feil	2
5	Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4 2022 ·International Journal of Molecular Sciences ·Christoph Keßler, Christoph Ruschil, Ahmed Abdelhak, Carlo Wilke, (unknown), Jens Kühle, Markus Krumbholz, Markus C. Kowarik, Rebecca Schüle	4
6	Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever 2021 ·Wiener Medizinische Wochenschrift ·(unknown), (unknown), Till‐Karsten Hauser, Sebastian Saur, Markus Krumbholz, Jörg Henes, Ulf Ziemann, Markus C. Kowarik	2
7	Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study 2020 ·Contemporary Clinical Trials Communications ·Ahmed Abdelhak, André Huss, Alexander Stahmann, Makbule Şenel, Markus Krumbholz, Markus C. Kowarik, Joachim Havla, Tania Kümpfel, Ingo Kleiter, (unknown), Uwe K. Zettl, (unknown), (unknown), Tim Friede, Albert C. Ludolph, Ulf Ziemann, Hayrettin Tumani	5
8	Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab 2020 ·PLoS ONE ·(unknown), (unknown), Christoph Ruschil, Ahmed Abdelhak, (unknown), Ulf Ziemann, Markus Krumbholz, Bernhard Hemmer, Markus C. Kowarik	19
9	Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany 2020 ·Clinical Neurology and Neurosurgery ·Sebastian Rauer, Muna‐Miriam Hoshi, Refik Pul, Mathias Wahl, Matthias Schwab, Judith Haas, Gisa Ellrichmann, Markus Krumbholz, Björn Tackenberg, Kai‐Uwe Saum, (unknown), Jost Leemhuis, (unknown), Orhan Aktaş	5
10	Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases 2019 ·Journal of Neuroinflammation ·Gildas Lepennetier, Zsuzsanna Hracskó, Marina Unger, Martijn van Griensven, Verena Grummel, Markus Krumbholz, Achim Berthele, Bernhard Hemmer, Markus C. Kowarik	106
11	The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients 2019 ·Frontiers in Immunology ·(unknown), Caterina Macrini, Markus Krumbholz, Paul J. Hensbergen, Agnes L. Hipgrave Ederveen, Stephan Winklmeier, Atay Vural, Aslı Kurne, (unknown), Frits Kamp, Lisa Ann Gerdes, Reinhard Hohlfeld, Manfred Wuhrer, Tania Kümpfel, Edgar Meinl	14
12	Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid 2015 ·Journal of Neuroinflammation ·Manfred Wuhrer, Maurice H. J. Selman, Liam A. McDonnell, Tania Kümpfel, Tobias Derfuß, Mohsen Khademi, Tomas Olsson, Reinhard Hohlfeld, Edgar Meinl, Markus Krumbholz	85
13	B cells in MS and NMO: pathogenesis and therapy 2014 ·Seminars in Immunopathology ·Markus Krumbholz, Edgar Meinl	64
14	Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells 2010 ·Brain Pathology ·Hema Mohan, Markus Krumbholz, Rakhi Sharma, Sylvia Eisele, Andreas Junker, Michael Sixt, Jia Newcombe, Hartmut Wekerle, Reinhard Hohlfeld, Hans Lassmann, Edgar Meinl	122
15	MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 2009 ·Brain ·Andreas Junker, Markus Krumbholz, Sylvia Eisele, Hema Mohan, (unknown), Robert A. Bittner, Hans Lassmann, Hartmut Wekerle, Reinhard Hohlfeld, Edgar Meinl	479
16	Lambert–Eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel 2008 ·Journal of Neuroimmunology ·Hannah Pellkofer, (unknown), Markus Krumbholz, Maarten J. Titulaer, Jan J.G.M. Verschuuren, (unknown), Raymond Voltz	22
17	Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis 2008 ·Journal of the Neurological Sciences ·Edgar Meinl, Markus Krumbholz, Tobias Derfuß, Andreas Junker, Reinhard Hohlfeld	60
18	B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation 2006 ·Annals of Neurology ·Edgar Meinl, Markus Krumbholz, Reinhard Hohlfeld	220
19	Expression and Function of Glial Cell Line-Derived Neurotrophic Factor Family Ligands and Their Receptors on Human Immune Cells 2005 ·The Journal of Immunology ·(unknown), (unknown), Tobias Derfuß, Markus Krumbholz, Reinhard Hohlfeld, Edgar Meinl	58
20	Expression and function of Toll-like receptor 3 in human astrocytes 2004 ·Journal of Neuroimmunology ·Cinthia Farina, Markus Krumbholz, Thomas Giese, Gunther Hartmann, Francesca Aloisi, Edgar Meinl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact